FTC Scrutiny Of Profit Seeking In Drug Supply Chain In Fact-Finding Mode
Executive Summary
Agency hears from experts on whether PBMs and group purchasing organizations operate under misaligned incentives.
You may also be interested in...
Will FTC Shakeup Impact Pharma?
With full slate of new commissioners FTC may expand focus to FDA regulatory issues; Commission has four cases against pharma companies in federal court and is fighting challenges to its authority to bring pay-for-delay suits.
Beyond Pay-For-Delay: US FTC Digs Deeper On Barriers To Generic Competition
FTC Acting Chairman Ohlhausen predicts agency will continue to focus on competition issues involving barriers to generics but says 'we need to learn more about how these markets are working today.'
Express Scripts-Medco Merger Closes With No Divestitures Needed
The FTC voted in a split 3-1 vote to close its investigation and allow Express Scripts’ $29.1 billion acquisition of rival PBM Medco to proceed.